Oscar Health, Inc. (OSCR) stock
OSCRNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3026% above fair value
$29.84−1.49 (-4.76%)
Close on Nov 17, 2026Market cap $9.21BP/E 21.3Yield –
Oscar Health r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Oscar Health
Oscar Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?